210 related articles for article (PubMed ID: 33328539)
1. Brain structural network alterations related to serum cortisol levels in drug-naïve, first-episode major depressive disorder patients: a source-based morphometric study.
Nguyen L; Kakeda S; Watanabe K; Katsuki A; Sugimoto K; Igata N; Shinkai T; Abe O; Korogi Y; Ikenouchi A; Yoshimura R
Sci Rep; 2020 Dec; 10(1):22096. PubMed ID: 33328539
[TBL] [Abstract][Full Text] [Related]
2. RELATIONSHIP BETWEEN THE CORTICAL THICKNESS AND SERUM CORTISOL LEVELS IN DRUG-NAÏVE, FIRST-EPISODE PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A SURFACE-BASED MORPHOMETRIC STUDY.
Liu X; Kakeda S; Watanabe K; Yoshimura R; Abe O; Ide S; Hayashi K; Katsuki A; Umeno-Nakano W; Watanabe R; Ueda I; Moriya J; Nakamura J; Korogi Y
Depress Anxiety; 2015 Sep; 32(9):702-8. PubMed ID: 26290363
[TBL] [Abstract][Full Text] [Related]
3. An independent component analysis reveals brain structural networks related to TNF-α in drug-naïve, first-episode major depressive disorder: a source-based morphometric study.
Kakeda S; Watanabe K; Nguyen H; Katsuki A; Sugimoto K; Igata N; Abe O; Yoshimura R; Korogi Y
Transl Psychiatry; 2020 Jun; 10(1):187. PubMed ID: 32522975
[TBL] [Abstract][Full Text] [Related]
4. PCLO rs2522833-mediated gray matter volume reduction in patients with drug-naive, first-episode major depressive disorder.
Igata R; Katsuki A; Kakeda S; Watanabe K; Igata N; Hori H; Konishi Y; Atake K; Kawasaki Y; Korogi Y; Yoshimura R
Transl Psychiatry; 2017 May; 7(5):e1140. PubMed ID: 28556829
[TBL] [Abstract][Full Text] [Related]
5. Brain structural abnormalities in adult major depressive disorder revealed by voxel- and source-based morphometry: evidence from the REST-meta-MDD Consortium.
Wang K; Hu Y; Yan C; Li M; Wu Y; Qiu J; Zhu X;
Psychol Med; 2023 Jun; 53(8):3672-3682. PubMed ID: 35166200
[TBL] [Abstract][Full Text] [Related]
6. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
Vreeburg SA; Hoogendijk WJ; van Pelt J; Derijk RH; Verhagen JC; van Dyck R; Smit JH; Zitman FG; Penninx BW
Arch Gen Psychiatry; 2009 Jun; 66(6):617-26. PubMed ID: 19487626
[TBL] [Abstract][Full Text] [Related]
7. Hormonal Dynamics Effect of Serum Insulin-Like Growth Factor I and Cortisol/Dehydroepiandrosterone Sulfate Ratio on Symptom Severity of Major Depressive Disorder.
Tajiri M; Suzuki Y; Tsuneyama N; Arinami H; Someya T
J Clin Psychopharmacol; 2019; 39(4):367-371. PubMed ID: 31211752
[TBL] [Abstract][Full Text] [Related]
8. Relationship between white matter integrity and serum cortisol levels in drug-naive patients with major depressive disorder: diffusion tensor imaging study using tract-based spatial statistics.
Liu X; Watanabe K; Kakeda S; Yoshimura R; Abe O; Ide S; Hayashi K; Katsuki A; Umene-Nakano W; Watanabe R; Ueda I; Nakamura J; Korogi Y
Br J Psychiatry; 2016 Jun; 208(6):585-90. PubMed ID: 26892846
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein and cortisol in drug-naïve patients with short-illness-duration first episode major depressive disorder: possible role of cortisol immunomodulatory action at early stage of the disease.
Cubała WJ; Landowski J
J Affect Disord; 2014 Jan; 152-154():534-7. PubMed ID: 24161452
[TBL] [Abstract][Full Text] [Related]
10. Hippocampus-driving progressive structural alterations in medication-naïve major depressive disorder.
Li Y; Wang C; Teng C; Jiao K; Song X; Tan Y; Xiao C; Zhang N; Zhong Y
J Affect Disord; 2019 Sep; 256():148-155. PubMed ID: 31176187
[TBL] [Abstract][Full Text] [Related]
11. A pilot investigation of differential neuroendocrine associations with fronto-limbic activation during semantically-cued list learning in mood disorders.
Peters AT; Smith RA; Kassel MT; Hagan M; Maki P; Van Meter A; Briceño EM; Ryan KA; Weldon AL; Weisenbach SL; Starkman MN; Langenecker SA
J Affect Disord; 2018 Oct; 239():180-191. PubMed ID: 30014958
[TBL] [Abstract][Full Text] [Related]
12. Association between resting-state brain functional connectivity and cortisol levels in unmedicated major depressive disorder.
Wang Y; Chen G; Zhong S; Jia Y; Xia L; Lai S; Zhao L; Huang L; Liu T
J Psychiatr Res; 2018 Oct; 105():55-62. PubMed ID: 30189325
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the hippocampal shape abnormality and serum cortisol levels in first-episode and drug-naïve major depressive disorder patients.
Watanabe R; Kakeda S; Watanabe K; Liu X; Katsuki A; Umeno-Nakano W; Hori H; Abe O; Yoshimura R; Korogi Y
Depress Anxiety; 2017 May; 34(5):401-409. PubMed ID: 28129464
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic gray-matter connectivity of the brain in major depressive disorder.
Zhang H; Qiu M; Ding L; Mellor D; Li G; Shen T; Peng D
J Affect Disord; 2019 May; 251():78-85. PubMed ID: 30909161
[TBL] [Abstract][Full Text] [Related]
15. Abnormal functional connectivity strength in first-episode, drug-naïve adult patients with major depressive disorder.
Shi Y; Li J; Feng Z; Xie H; Duan J; Chen F; Yang H
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109759. PubMed ID: 31499128
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin and depressive symptoms in patients with first-episode drug-naïve major depressive disorder: The mediating role of hypothalamic-pituitary-adrenal axis.
Zhang C; Dong Y; Li S; Li M; Gao Y; Liu Y; Liu X; Zhou C; Li J
Asia Pac Psychiatry; 2024 Mar; 16(1):e12552. PubMed ID: 38348641
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic-pituitary-adrenal axis activity and cognition in major depression: The role of remission status.
Salvat-Pujol N; Labad J; Urretavizcaya M; de Arriba-Arnau A; Segalàs C; Real E; Ferrer A; Crespo JM; Jiménez-Murcia S; Soriano-Mas C; Menchón JM; Soria V
Psychoneuroendocrinology; 2017 Feb; 76():38-48. PubMed ID: 27883963
[TBL] [Abstract][Full Text] [Related]
18. Cognitive functioning and cortisol profiles in first episode major depression.
Hansson PB; Murison R; Lund A; Hammar Å
Scand J Psychol; 2015 Aug; 56(4):379-83. PubMed ID: 26032571
[TBL] [Abstract][Full Text] [Related]
19. High-field magnetic resonance imaging of structural alterations in first-episode, drug-naive patients with major depressive disorder.
Chen Z; Peng W; Sun H; Kuang W; Li W; Jia Z; Gong Q
Transl Psychiatry; 2016 Nov; 6(11):e942. PubMed ID: 27824357
[TBL] [Abstract][Full Text] [Related]
20. Activity of the hypothalamic-pituitary-adrenal axis and inflammatory mediators in major depressive disorder with or without metabolic syndrome.
Martinac M; Babić D; Bevanda M; Vasilj I; Glibo DB; Karlović D; Jakovljević M
Psychiatr Danub; 2017 Mar; 29(1):39-50. PubMed ID: 28291973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
